ACB Republic of Ireland Regional Scientific Meeting
Friday 4th March 2022 (Virtual Meeting)

09:10      Welcome address: Dr Jennifer Brady, Chair ACB (Republic of Ireland Region)

Session 1
Chair: Dr Brendan Byrne, Principal Clinical Biochemist, Mater Hospital

09:15      Prof Mark Sherlock, Consultant Endocrinologist, Beaumont Hospital, Dublin
               Adrenal Nodules

10.00      Prof Martina Hennessy, Director of the Wellcome HRB CRF, St James’s Hospital, Dublin
               Bringing Cell and Gene Therapies into Clinical Practice – The Last Mile

10.45 Coffee break

Session 2
Chair: Dr Paula O’Shea, Consultant Clinical Biochemist, University Hospital Galway

11.00     Caroline Joyce, Principal Clinical Biochemist, Cork University Hospital
              Recent updates in Gestational Trophoblastic Disease

11.40     Dr Geoffrey Maher, Senior Scientist in Genetics, Imperial College London
              Utilising circulating tumour DNA to determine the origin of human chorionic gonadotropin-secreting tumours

12:20     Members’ papers

12:50     Prize for best members’ paper

12.55     Closing remarks: Dr Jennifer Brady, Chair ACB (Republic of Ireland Region)

13.00 Lunch

13:30     AGM – open to members of the region only

Call for Abstract Submission

All delegates are invited to submit an abstract for oral presentation. Authors of abstracts will be selected to pre-record a short PowerPoint presentation to be shown at this virtual meeting (via MS Teams). From these recordings judges will select a winner who will be awarded a prize on the day. We welcome abstracts relating to audit, novel research or case presentations once consent has been obtained.

Abstracts should be submitted to [email protected] with the subject heading “ABSTRACT SUBMISSION” by 5pm on Wednesday 16th Feb 2022. Successful authors will be notified by Friday 25th Feb 2022.

Abstract submission guidelines for the ACB RoI Region Meeting 4th March 2022 – instructions for authors

• Abstracts must be typed in Microsoft Office Word format only, using single spacing of 12-point font size in Arial font.
• The title of the abstract should be clear, concise and informative
• The author’s initials and surname should appear below the title. Author’s institutions should be listed numerically, if more than one. The presenting author should be highlighted and their email address included.
• The text of the abstract (excluding title, authors and references) must not exceed 250 words. Figures and tables are not allowed.
• The abstract text should clearly describe the study/audit, results and conclusions. Headings within the text are unnecessary. All abbreviations must be clearly defined. Statistical tests used must be specified. All abbreviations must be clearly defined.
• The presenter is responsible for the content of the abstract and assuring that all authors have been informed of the presentation and have agreed the data submitted.
•    The submitting author should be registered to attend the meeting.